GLP-1 RA Shortage Report
Description There are supply disruptions for Ozempic (s/c Semaglutide) and Trulicity (s/c Dulaglutide), expected to last until January 2023. Patients with both Type 1 and Type 2 diabetes are being treating increasingly with these weekly GLP-1 ...